With the development of novel techniques, such as cSLO, which allows the quantification of rhodopsin, efforts should be made to determine whether rhodopsin might have an increased sensitivity for the diagnosis and monitoring of neurodegenerative diseases. This evidence concerns the gene RHO and neurodegenerative disease.